A pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renal dialysis patients: Preliminary report()

PURPOSE: Patients with end-stage renal disease (ESRD) on hemodialysis (HD) are considered particularly susceptible to infection with SARS-CoV2 on the basis of the immunodeficiency associated with advanced age, comorbidity burden, medication use, and need for frequent visits to dialysis clinics. In p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuthill, Cynthia W., Awad, Ahmed, Parrigon, Mary, Ershler, William B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977612/
https://www.ncbi.nlm.nih.gov/pubmed/36881981
http://dx.doi.org/10.1016/j.intimp.2023.109950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977612/
https://www.ncbi.nlm.nih.gov/pubmed/36881981
http://dx.doi.org/10.1016/j.intimp.2023.109950

Ejemplares similares